MIV Therapeutics Announces Live VESTASYNC Follow-Up Case Performed At TCT Conference
October 23, 2007 07:30 ET
|
MIV Therapeutics, Inc.
ATLANTA, Oct. 23, 2007 (PRIME NEWSWIRE) -- MIV Therapeutics, Inc. (OTCBB:MIVT) (Frankfurt:MIV), a leading developer of next-generation coatings and advanced drug delivery systems for cardiovascular...
MIV Therapeutics Builds Strength of Drug-Delivery Technologies Program with Appointment of Dr. Dean-Mo Lui as Chief Scientist
March 31, 2005 06:00 ET
|
MIV Therapeutics, Inc.
VANCOUVER, British Columbia, March 31, 2005 (PRIMEZONE) -- MIV Therapeutics, Inc. (OTCBB:MIVT) a developer of next-generation biocompatible stent coatings and drug delivery technologies, today...
MIVT Vice President of Coatings, nominated for the 2004 World Technology Award
September 09, 2004 09:00 ET
|
MIV Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 9, 2004 (PRIMEZONE) -- MIV Therapeutics Inc. (OTCBB:MIVT) is pleased to announce that Dr. Tom Troczynski, Ph.D., MIVT Vice President of Coatings and Professor of...